Dr. Reddys Laboratories Ltd.

United States Food & Drug Administration (USFDA) has completed a GMP inspection at Dr. Reddy’s Laboratories’ API Middleburgh facility in New York. The inspection was conducted from May 12, 2025 to May 16, 2025. The company has been issued a Form 483 with two observations, which it will address within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.